Clinical trial
Combination Chemotherapy With or Without Irinotecan in Treating Patients With…
NCT00005979 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00005979 |
|---|---|
| Title | Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer |
| Official title | Phase III Randomized Study of Intensive Adjuvant Chemotherapy for Resected Colon Cancer at High Risk of Recurrence |
| Lead sponsor | UNICANCER, Other |
| Collaborators | Federation Francophone de Cancerologie Digestive |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFIRI regimen, fluorouracil, irinotecan hydrochloride, leucovorin calcium |
| Start date | Jul 22, 1998 |
| Primary completion | Sep 26, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 17, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: